- The role of 11C-choline and 18F-fluorocholine positron emission tomography (PET) and PET/CT in prostate cancer: a systematic review and meta-analysisMartin H Umbehr
University of Zurich, Zurich, Switzerland
Eur Urol 64:106-17. 2013..The role of positron emission tomography (PET) and PET/computed tomography (PET/CT) in prostate cancer (PCa) imaging is still debated, although guidelines for their use have emerged over the last few years...
- ProCOC: the prostate cancer outcomes cohort studyMartin Umbehr
Horten Centre for patient oriented research and knowledge transfer, University of Zurich, University Hospital of Zurich, Postfach Nord, 8091 Zurich, Switzerland
BMC Urol 8:9. 2008..These questions can be addressed in the context of a cohort study...
- Combined magnetic resonance imaging and magnetic resonance spectroscopy imaging in the diagnosis of prostate cancer: a systematic review and meta-analysisMartin Umbehr
Horten Centre for patient oriented research and knowledge transfer, University of Zurich, Zurich, Switzerland
Eur Urol 55:575-90. 2009..Magnetic resonance imaging (MRI) combined with magnetic resonance spectroscopy imaging (MRSI) emerged as a promising test in the diagnosis of prostate cancer and showed encouraging results...
- Adverse event assessment of antimuscarinics for treating overactive bladder: a network meta-analytic approachThomas M Kessler
Horten Centre for Patient Oriented Research, University of Zurich, Zurich, Switzerland
PLoS ONE 6:e16718. 2011..In addition, the assessment of the broad variety of adverse events is dissatisfying. Our aim was to compare adverse events of antimuscarinics using a network meta-analytic approach that overcomes shortcomings of conventional analyses...